Orphazyme postpones financial report
The Danish biotech company, which has had some headwind, pushes back announcing its results for H1.
BY MATHIAS JULIUS FALKENGAARD, TRANSLATED BY NIELSINE NIELSEN
The biotech company Orphazyme, which is based in Copenhagen, postpones the publication of its fiscal report for the first half-year of 2021 by a week, so the report will now be released on Aug. 31.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
